XBI
NYSE
$150.94
STATE STREET(R) SPDR(R) S&P(R) BIOTECH ETF (XBI)
Sector:
Healthcare
Industry:
Biotechnology
Net assets
$11B
Inception date
January 31, 2006
Expense ratio
0.35%
Sharpe Ratio
2.03
Price Chart
Valuation
Net assets$11B
P/S9.63
P/B5.25
Profitability
Profit Margin-12.4%
Operating Margin-3849.6%
Financial Health
Debt-to-Equity28.9%
Growth & Risk
EPS 5Y CAGR+5.09%
Revenue 5Y CAGR+50.12%
FCF 5Y CAGR+26.52%
Dividends 5Y CAGR+12.45%
Beta (5Y)0.96
Sharpe Ratio2.03